LEADERS, BUT WE DON’T KNOW IT. CLINICAL RESEARCH IN ITALY
Paola Burioli, Romagnolo Institute for the Study of Tumors Dino Amadori (IRCCS); Maria Chiara Carrozza, President of the National Research Council (CNR); Marcello Cattani, President of Farmindustria; Franco Locatelli, President of the Superior Health Council; Carlo Nicora, Vice President of the Italian Federation of Health and Hospital Companies (FIASO), General Director of the National Cancer Institute in Milan. Moderated by Mattia Altini, President of the Italian Society of Leadership and Management in Medicine (SIMM), Director of Hospital Care in the Emilia-Romagna Region.
In a healthcare system of great value and still universal, financial tensions and the planned post-Covid funding are risking undermining medium-term sustainability, exacerbating inequalities and territorial differences. This event is an opportune moment to ask whether data analysis and the structuring of the competitive model of clinical research can provide a key to understanding the development and sustainability of the country’s system. In particular, these elements could be used to promote collaboration between the academic and industrial worlds: in this way, clinical research could once again become a clear and fundamental driver of development.
